“…Risk was lower with increasing maternal height from <145 cm to 145–150 cm (aHR: 0.78, 95% CI: (0.65 to 0.94)) to ≥150 cm (aHR: 0.57, 95% CI: (0.47 to 0.68)), four or more antenatal care (ANC) visits (aHR: 0.67, 95% CI: (0.53 to 0.86)) and education >5 years (aHR: 0.75, 95% CI: (0.62 to 0.92)). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Factors associated with the achievement of pathologic complete response (pCR) and survival were studied among hormone receptor positive (HR+) and negative (HR–) eBC. RESULTS: A total of 280 HR+ (61% HER2-low), and 231 HR– (28% HER2-low) eBC were included. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In univariate analysis (log-rank test (p)/Cox regression (HR, 95% CI, p)), polypharmacy (p = 0.036/HR = 2.83, 95% CI = 1.02–7.90, p = 0.047), calcium channel blockers (p = 0.046/HR = 2.47, 95% CI = 0.97–6.27, p = 0.057) and proton pump inhibitors (p = 0.015/HR = 3.16, 95% CI = 1.18–8.41, p = 0.022) had a significant negative impact on RFS in RC patients, statins (p = 0.025/HR = 0.14, 95% CI = 0.02–1.06, p = 0.057) a positive effect on RFS in FD patients, angiotensin-converting enzyme inhibitors (p = 0.008/HR = 10.74, 95% CI = 1.20–96.17, p = 0.034) and magnesium (p = 0.042/HR = 5.28, 95% CI = 0.88–31.59, p = 0.067) a negative impact on CSS in FD patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…This difference was explainable by a significantly higher hazard of recurrence in years 1 to 5 in HER2+ HR- compared to HER2+ HR+ patients, with a mean risk of recurrence of 9%/year for HR- versus 5%/year in HR+ patients (hazard ratio 0.59, P = 0.002 for years 1 to 5). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…HRs were increased for cancer of the stomach (men, HR 1.23 [1.04, 1.46]; women, HR 1.78 [1.49, 2.13]), liver (men, HR 2.00 [1.67, 2.40]; women, HR 1.55 [1.14, 2.10]), pancreas (men, HR 1.53 [1.30, 1.79]; women, HR 1.25 [1.02,1.53]), endometrium (HR 1.42 [1.27, 1.58]) and kidney (men, HR 1.30 [1.12, 1.49]; women, HR 1.47 [1.23, 1.77]). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We also observed suggestive associations in either short or long sleepers, which did not reach overall significance (P(trend) >0.05), including increased risks in male short sleepers for cancers of head and neck (HR(<5vs.7-8 hours) = 1.39; 95%CI:1.00–1.95), bladder (HR(5-6vs.7-8 hours) = 1.10; 95%CI:1.00–1.20), thyroid (HR(<5 vs. 7–8 hours) = 2.30; 95%CI:1.06, 5.02), Non-Hodgkin Lymphoma (NHL) (HR(5-6vs.7-8 hours) = 1.17; 95%CI:1.02–1.33), and myeloma (HR(<5vs.7-8 hours) = 2.06; 95%CI:1.20–3.51). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Poor PS in younger and elderly patients was related to shorter DFS (HR=1.95, p=0.002; HR=1.6, p=0.035, respectively) and overall survival (OS; HR=2.28, p<0.001; HR=2.03, p=0.002). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: Mothers with perinatal losses had increased crude mortality compared with mothers without; total: HR 1.3 (95% CI 1.3 to 1.4), cardiovascular: HR 1.8 (1.5 to 2.1), non-cardiovascular: HR 1.3 (1.2 to 1.4). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Additionally, the reduced 8-gene signature was sufficient and effective in predicting survival in liver and five other cancers: liver (HR = 2.36, P = 0.0003; HR = 2.43, P = 0.0002 and HR = 3.45, P = 0.0007), head and neck (HR = 1.64, P = 0.004), renal papillary cell (HR = 2.31, P = 0.04), lung (HR = 1.45, P = 0.03), pancreas (HR = 1.96, P = 0.006) and endometrial (HR = 2.33, P = 0.003). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…This study aimed to explore factors associated with hrHPV infection and high-grade cervical neoplasia in hrHPV-positive (hrHPV+) women from Paraguay. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Eighty‐six patients undergoing EITs were divided into three groups: RD1 (dexmedetomidine at an initial dose of 0.5 μg/kg for 10 min adjusted to 0.2 μg kg(−1) hr(−1) throughout EIT), RD2 (dexmedetomidine at an initial dose of 0.5 μg/kg for 10 min adjusted to 0.4 μg kg(−1) hr(−1) throughout EIT), and RD3 (dexmedetomidine at an initial dose of 0.5 μg/kg for 10 min adjusted to 0.6 μg kg(−1) hr(−1) throughout EIT). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…After adjustment for confounders, rates of VLOSLP were higher among migrants from Africa (hazard ratio [HR] = 2.0, 95% CI = 1.4–2.7), North America (HR = 1.4, 95% CI = 1.0–1.9, P = .04), Europe (HR = 1.3, 95% CI = 1.2–1.4), Russian-Baltic regions (HR = 1.6, 95% CI = 1.4–1.9), and Finland (HR = 1.6, 95% CI = 1.5–1.7). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Apixaban was associated with a lower risk of stroke/SE and MB compared with dabigatran (stroke/SE: HR = .65; 95% CI = .47‐.89; MB: HR = .60; 95% CI = .49‐.73) and rivaroxaban (stroke/SE: HR = .72; 95% CI = .59‐.86; MB: HR = .50; 95% CI = .45‐.55). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The meta-analysis indicated that positive surgical margin (pooled HR = 1.47; 95% CI:1.24–1.73; P < 0.001), higher Fuhrman grade (pooled HR = 1.58; 95% CI:1.10–2.28; P = 0.013), higher pathological stage (pooled HR = 1.72; 95% CI:1.40–2.12; P < 0.001) and large tumor size (pooled HR = 1.09; 95% CI:1.03–1.16; P = 0.003) were significantly associated with recurrence risk. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Studies on the fusion-inhibitory peptides derived from the heptad repeat 1 and 2 (HR1 and HR2) regions of the HIV-1 envelope glycoprotein gp41 provided crucial information on the viral fusogenic mechanism. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Additionally, the elevated platelet-to-lymphocyte ratio was related to a poor OS (HR = 1.29, 95% CI: 1.07–1.54, P = .007), CSS (HR = 1.14, 95%CI = 0.98–1.34, P = .02) and PFS (HR = 1.2, 95%CI: 1.08–1.34, P = .0008). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…However, innovative HR interventions and messaging may also develop in response to such a crisis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…PURPOSE: High-risk human papillomavirus (HR-HPV) infection is widely known as the major cause of cervical cancer and there are notable differences in HR-HPV prevalence and genotype distribution in different populations. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…There were no significant differences between under-dosing and on-label dosing with respect to stroke/systematic embolism (HR: 1.01, 95% CI: 0.93–1.09), major bleeding (HR: 0.98, 95% CI: 0.77–1.19), intracranial haemorrhage (HR: 1.07, 95% CI: 0.74–1.40), gastrointestinal bleeding (HR: 1.10, 95% CI: 0.82–1.39), and myocardial infarction (HR: 1.07, 95% CI: 0.89–1.25), except for an increased risk of death (HR: 1.37, 95% CI: 1.01–1.73). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…It is demonstrated that UACR predicted an increased risk of stroke using cutoff value of either 0.43 (HR, 2.39; 95% CI: 1.24 - 4.61; P <0.01), 10 mg/g (HR, 1.60; 95% CI: 1.30 - 1.97; P < 0.01) or 30 mg/g (HR, 1.84; 95% CI: 1.49 - 2.28; P < 0.01). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso